Immatics N.V. (IMTX)
USD 6.73
(-6.27%)
USD 6.73
(-6.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -203.07 Million EUR | -51.59% |
| 2022 | -133.95 Million EUR | -8.78% |
| 2021 | -123.14 Million EUR | 38.84% |
| 2020 | -201.34 Million EUR | -101.1% |
| 2019 | -100.11 Million EUR | -154.32% |
| 2018 | -39.36 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -89.58 Million EUR | 55.88% |
| 2024 Q2 | -122.2 Million EUR | -57.09% |
| 2023 FY | -203.07 Million EUR | -51.59% |
| 2023 Q4 | -203.07 Million EUR | -203.15% |
| 2023 Q3 | -66.98 Million EUR | 41.02% |
| 2023 Q2 | -113.58 Million EUR | -10.33% |
| 2023 Q1 | -102.95 Million EUR | 23.14% |
| 2022 Q4 | -133.95 Million EUR | 17.19% |
| 2022 Q3 | -161.76 Million EUR | 34.96% |
| 2022 Q2 | -248.71 Million EUR | -4.48% |
| 2022 Q1 | -238.05 Million EUR | -93.32% |
| 2022 FY | -133.95 Million EUR | -8.78% |
| 2021 Q1 | -188.98 Million EUR | 6.14% |
| 2021 Q4 | -123.14 Million EUR | 20.19% |
| 2021 Q3 | -154.29 Million EUR | -0.82% |
| 2021 Q2 | -153.03 Million EUR | 19.02% |
| 2021 FY | -123.14 Million EUR | 38.84% |
| 2020 Q2 | -78.58 Million EUR | -12.57% |
| 2020 Q4 | -201.34 Million EUR | 11.24% |
| 2020 Q3 | -226.84 Million EUR | -188.67% |
| 2020 FY | -201.34 Million EUR | -101.1% |
| 2020 Q1 | -69.8 Million EUR | 30.28% |
| 2019 FY | -100.11 Million EUR | -154.32% |
| 2019 Q4 | -100.11 Million EUR | -300.0% |
| 2019 Q2 | -25.02 Million EUR | -146.98% |
| 2019 Q1 | 53.27 Million EUR | 0.0% |
| 2019 Q3 | -25.02 Million EUR | 0.0% |
| 2018 FY | -39.36 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2616.951% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 223.546% |
| IO Biotech, Inc. | -140.69 Million USD | -44.329% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -566.678% |
| Organovo Holdings, Inc. | -1.5 Million USD | -13375.116% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -7615.015% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16991.492% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1241.724% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -263.508% |
| Savara Inc. | 153 Thousand USD | 132825.49% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -790.033% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -557.994% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3014.291% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6389.896% |
| Soligenix, Inc. | -4.95 Million USD | -4001.101% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2378.018% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1133.698% |
| Century Therapeutics, Inc. | 847 Thousand USD | 24075.207% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 692.594% |
| Precision BioSciences, Inc. | -85.41 Million USD | -137.759% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -1.626% |
| Kura Oncology, Inc. | -20.11 Million USD | -909.395% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2160.592% |
| Dyadic International, Inc. | -6.37 Million USD | -3083.864% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -396.188% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -31.739% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -6251.892% |
| Autolus Therapeutics plc | -186.59 Million USD | -8.827% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1174.525% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 26.369% |
| GRI Bio, Inc. | -1.79 Million USD | -11219.398% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -510.608% |
| IGM Biosciences, Inc. | -72.6 Million USD | -179.688% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 234.527% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -300.857% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6939.002% |
| Opthea Limited | 28.15 Million USD | 821.195% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -393.068% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 736.883% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -291.558% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1109.542% |
| Surrozen, Inc. | -32.66 Million USD | -521.694% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4730.988% |
| Cingulate Inc. | 3.08 Million USD | 6687.443% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1171.033% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 283.16% |
| Acelyrin, Inc. | -216.9 Million USD | 6.378% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -367.451% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1293.098% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 35.897% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -162.192% |
| ADMA Biologics, Inc. | 90.06 Million USD | 325.468% |
| PureTech Health plc | -167.19 Million USD | -21.456% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3083.414% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2638.269% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -57.28% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -702.902% |
| Synaptogenix, Inc. | -28.66 Million USD | -608.511% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -21595.513% |
| ChromaDex Corporation | -24.04 Million USD | -744.436% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2276.985% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2694.767% |
| Exelixis, Inc. | -73.05 Million USD | -177.988% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 431.505% |
| Better Therapeutics, Inc. | -860 Thousand USD | -23512.791% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -745.667% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 15.868% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2760.141% |
| Seer, Inc. | -4.24 Million USD | -4689.387% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 16293.78% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -435.55% |
| Gritstone bio, Inc. | 39.49 Million USD | 614.231% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -141.46% |
| Avid Bioservices, Inc. | 169.72 Million USD | 219.644% |
| Insmed Incorporated | 721.62 Million USD | 128.141% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 7862.615% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5680.529% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 429.306% |
| MediWound Ltd. | -5.32 Million USD | -3715.671% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 661.541% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2749.315% |
| OmniAb, Inc. | 9.2 Million USD | 2306.563% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 336.208% |
| Zai Lab Limited | -775 Million USD | 73.797% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 159.629% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -5.101% |
| Veracyte, Inc. | -203.82 Million USD | 0.37% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2138.179% |
| FibroGen, Inc. | 56.76 Million USD | 457.725% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -74.636% |
| ContextLogic Inc. | -232 Million USD | 12.47% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2318.076% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -7083.025% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -83.712% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.424% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 32435.987% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5978.12% |
| ImmuCell Corporation | 10.99 Million USD | 1947.676% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 112.939% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -729.805% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -141.46% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -475.873% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -19.162% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3668.266% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -119.835% |
| Vaxxinity, Inc. | 10.13 Million USD | 2104.244% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 127.581% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1785.944% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5781.53% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1243.815% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4986.189% |
| Senti Biosciences, Inc. | 1.74 Million USD | 11770.69% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -28023.702% |
| Apollomics, Inc. | -27.39 Million USD | -641.267% |
| 89bio, Inc. | -289.05 Million USD | 29.746% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4844.626% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -8664.248% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -400.518% |
| Ardelyx, Inc. | 34.51 Million USD | 688.404% |
| Pluri Inc. | 22.82 Million USD | 989.526% |
| Prothena Corporation plc | -608.34 Million USD | 66.619% |
| Pulmatrix, Inc. | -10.41 Million USD | -1849.41% |
| Celularity Inc. | 65.19 Million USD | 411.505% |
| MeiraGTx Holdings plc | -40.3 Million USD | -403.871% |
| Omeros Corporation | 331.17 Million USD | 161.318% |
| Ainos, Inc. | 4.07 Million USD | 5079.735% |
| Humacyte, Inc. | -22.48 Million USD | -803.095% |
| Mesoblast Limited | 55.96 Million USD | 462.865% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -726.328% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -557.163% |
| Blueprint Medicines Corporation | 702.83 Million USD | 128.893% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -7.89% |
| Summit Therapeutics Inc. | 34.67 Million USD | 685.655% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3249.885% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -407.206% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -82.286% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -238.766% |
| Cytokinetics, Incorporated | 642.37 Million USD | 131.613% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3387.378% |
| Nutriband Inc. | -251.65 Thousand USD | -80593.166% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -495.182% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.636% |
| Evogene Ltd. | -19.63 Million USD | -934.277% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -317.221% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2098.397% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 114.889% |
| BioLineRx Ltd. | 7.33 Million USD | 2868.13% |
| Atai Life Sciences N.V. | -28.55 Million USD | -611.079% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -73.496% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 516.708% |
| MediciNova, Inc. | -50.78 Million USD | -299.874% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -157.687% |
| MiMedx Group, Inc. | -33.9 Million USD | -499.009% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -13.463% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -114.109% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 30.872% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1149.71% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4547.438% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 13.38% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -115.548% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -112.203% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -419.719% |
| Allakos Inc. | -24.97 Million USD | -713.093% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1277.493% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -49.978% |
| BioAtla, Inc. | -109.01 Million USD | -86.284% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1797.058% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -857.742% |
| Precigen, Inc. | -481 Thousand USD | -42118.295% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -23455.573% |
| XOMA Corporation | -29 Million USD | -600.241% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1126.268% |
| Incyte Corporation | -3.17 Billion USD | 93.604% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2152.329% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -62.93% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -996.499% |
| CRISPR Therapeutics AG | -150.84 Million USD | -34.622% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 2.447% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -118.913% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -23535.217% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4724.687% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 278.946% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 282290.601% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -811.118% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -10.001% |
| Chimerix, Inc. | -25.51 Million USD | -695.822% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1769.535% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -10209.106% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -244.917% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -839.842% |
| Portage Biotech Inc. | -4.98 Million USD | -3976.892% |
| OncoCyte Corporation | -6.56 Million USD | -2994.164% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 22728.377% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2322.937% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4357.549% |
| Purple Biotech Ltd. | -14.13 Million USD | -1336.342% |
| NextCure, Inc. | -6.47 Million USD | -3035.248% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1116.559% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2630.12% |
| Generation Bio Co. | 31.44 Million USD | 745.733% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 44.939% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 225.552% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2573.381% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 27688.559% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -311.873% |
| Novavax, Inc. | -298.29 Million USD | 31.923% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -6022.198% |
| Curis, Inc. | -23.88 Million USD | -750.128% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3837.059% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3171.102% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2121.405% |
| Bicycle Therapeutics plc | -481.46 Million USD | 57.823% |
| BeiGene, Ltd. | -2.25 Billion USD | 90.987% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1745.824% |
| Alector, Inc. | -35.63 Million USD | -469.829% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -9.421% |
| Erasca, Inc. | -37.21 Million USD | -445.652% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4020.739% |
| Aura Biosciences, Inc. | -21.52 Million USD | -843.415% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1633.877% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2162.353% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -15667.614% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1067.337% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 153.616% |
| Histogen Inc. | -7.48 Million USD | -2612.301% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2749.315% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -15.888% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -146.205% |
| Galecto, Inc. | -21.21 Million USD | -857.155% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 131.815% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 16.212% |
| Molecular Templates, Inc. | 707 Thousand USD | 28822.772% |
| PDS Biotechnology Corporation | -32.7 Million USD | -520.84% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -22.358% |
| Amarin Corporation plc | -191.04 Million USD | -6.297% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1236.883% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1664.752% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -529.245% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -490.732% |
| Onconetix, Inc. | 5.33 Million USD | 3908.917% |
| MacroGenics, Inc. | -66.98 Million USD | -203.157% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -162.983% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -302.111% |
| Adagene Inc. | -87.62 Million USD | -131.743% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -199.588% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -207.887% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -318.623% |
| SciSparc Ltd. | -2.06 Million USD | -9733.898% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1593.421% |
| Minerva Neurosciences, Inc. | 41 Million USD | 595.241% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -15.799% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -556.696% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 274.17% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -124.958% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 110.86% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3045.349% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2875.385% |
| 2seventy bio, Inc. | 181.71 Million USD | 211.752% |
| Clene Inc. | 3.34 Million USD | 6179.94% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -844.029% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3047.109% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -9708.496% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1056.172% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -162910.235% |
| Absci Corporation | -72.59 Million USD | -179.718% |
| XBiotech Inc. | -200.02 Million USD | -1.523% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3798.445% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4584.761% |
| Entera Bio Ltd. | -10.62 Million USD | -1810.528% |
| Trevena, Inc. | 2.25 Million USD | 9093.357% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -70.998% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -757.668% |
| INmune Bio, Inc. | -25.41 Million USD | -699.142% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -681.048% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -294.234% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6814.198% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2925.518% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2085.61% |
| Jaguar Health, Inc. | 29.39 Million USD | 790.926% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1542.156% |
| NexImmune, Inc. | -3.13 Million USD | -6380.317% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -92.407% |
| Clearmind Medicine Inc. | -3.94 Million USD | -5050.614% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -82816.85% |
| Kronos Bio, Inc. | -36.05 Million USD | -463.238% |
| Innoviva, Inc. | 255.56 Million USD | 179.46% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 153.729% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -649.336% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2258.253% |
| Verastem, Inc. | -37.27 Million USD | -444.745% |
| ProKidney Corp. | -56.23 Million USD | -261.103% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 14026.77% |
| Imunon, Inc. | -4.21 Million USD | -4719.106% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -274.281% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1508.604% |
| ImmunityBio, Inc. | 618.22 Million USD | 132.847% |
| Korro Bio, Inc. | -132.94 Million USD | -52.75% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 158.588% |
| Kineta, Inc. | -4.54 Million USD | -4371.922% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -51.455% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2135.788% |
| GT Biopharma, Inc. | -1.02 Million USD | -19789.324% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 35.88% |
| Celularity Inc. | 65.19 Million USD | 411.505% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -6308.015% |
| CalciMedica, Inc. | -5.53 Million USD | -3572.152% |
| Cibus, Inc. | -8.07 Million USD | -2413.865% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -265.142% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1888.154% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4701.844% |
| Kodiak Sciences Inc. | -103.87 Million USD | -95.495% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -510.682% |
| Annexon, Inc. | -193.75 Million USD | -4.808% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 564183.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1060.466% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3297.524% |
| Moderna, Inc. | -2.9 Billion USD | 93.014% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -432.405% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 119.262% |
| Vor Biopharma Inc. | 4.3 Million USD | 4822.558% |
| Eyenovia, Inc. | 1.25 Million USD | 16233.287% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4801.521% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 854.767% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -147.459% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -20.708% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6161.795% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -54.482% |
| Immunocore Holdings plc | -358.59 Million USD | 43.37% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -639.377% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 540.05% |
| Alkermes plc | -166.73 Million USD | -21.789% |
| Arcellx, Inc. | -296.95 Million USD | 31.617% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 9204.118% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1245.024% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -170.493% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -879.737% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -902633.941% |
| Moolec Science SA | 117.61 Thousand USD | 172755.081% |
| Biomea Fusion, Inc. | -166.57 Million USD | -21.913% |
| RenovoRx, Inc. | -1.17 Million USD | -17212.02% |
| Geron Corporation | 14.76 Million USD | 1475.72% |
| Mereo BioPharma Group plc | -51.46 Million USD | -294.548% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -744.823% |
| Royalty Pharma plc | 5.65 Billion USD | 103.589% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -43.593% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2805.39% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -753.773% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3686.6% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -44.297% |
| Humacyte, Inc. | -22.48 Million USD | -803.095% |
| Structure Therapeutics Inc. | -124.33 Million USD | -63.32% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 27688.559% |
| Genelux Corporation | -6.89 Million USD | -2843.47% |
| ESSA Pharma Inc. | -33.62 Million USD | -503.987% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2626.138% |
| Notable Labs, Ltd. | -9.77 Million USD | -1977.23% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -269459.561% |
| Mustang Bio, Inc. | -3.73 Million USD | -5335.493% |
| Immunovant, Inc. | -635.22 Million USD | 68.032% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12612.863% |
| Vericel Corporation | 1.27 Million USD | 16002.114% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 114.706% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5181.404% |
| Acasti Pharma Inc. | -23 Million USD | -782.721% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5930.775% |
| Vaxcyte, Inc. | -368.22 Million USD | 44.852% |
| Orgenesis Inc. | 21.78 Million USD | 1032.198% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -121.378% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -813.413% |
| GH Research PLC | -78.07 Million USD | -160.089% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -993.597% |
| PepGen Inc. | -60.67 Million USD | -234.712% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -783.835% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4863.135% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -23455.573% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4730.988% |
| Silo Pharma, Inc. | -3.52 Million USD | -5661.982% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 203640.178% |
| Belite Bio, Inc | -87.27 Million USD | -132.689% |
| Pharming Group N.V. | 109.8 Million USD | 284.939% |
| XOMA Corporation | -29 Million USD | -600.241% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -661.731% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -996.499% |
| Bionomics Limited | 227 Million USD | 189.454% |
| Xencor, Inc. | 29.64 Million USD | 785.029% |
| Replimune Group, Inc. | 1.41 Million USD | 14481.728% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2091.859% |
| Cassava Sciences, Inc. | -121.13 Million USD | -67.638% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -60.635% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4775.129% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1292.416% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1723.132% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3047.109% |
| MEI Pharma, Inc. | -3.7 Million USD | -5380.972% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -207.114% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -902633.941% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -21526.198% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 191675.472% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -754.816% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3002.674% |
| HilleVax, Inc. | -165.48 Million USD | -22.712% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2629.837% |
| Tharimmune, Inc. | -10.93 Million USD | -1757.005% |
| Genprex, Inc. | -6.73 Million USD | -2913.968% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2380.404% |
| Immunic, Inc. | -45.34 Million USD | -347.883% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -129.561% |
| Aptorum Group Limited | 1.35 Million USD | 15064.121% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -19.962% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2380.404% |
| OKYO Pharma Limited | -826.84 Thousand USD | -24459.532% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -26068.41% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 17236.709% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 11247.311% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 202.527% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3519.614% |
| bluebird bio, Inc. | 108.57 Million USD | 287.039% |
| DBV Technologies S.A. | -126.98 Million USD | -59.915% |
| Compugen Ltd. | -12.9 Million USD | -1473.698% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -15667.614% |
| Peak Bio, Inc. | 10.34 Million USD | 2063.896% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1861.65% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1768.513% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2885.007% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -603.346% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -71656.184% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -547.318% |
| Benitec Biopharma Inc. | -50.58 Million USD | -301.467% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -94.627% |
| Adicet Bio, Inc. | -138.78 Million USD | -46.318% |
| Prime Medicine, Inc. | -27.94 Million USD | -626.781% |
| Aditxt, Inc. | 18.12 Million USD | 1220.641% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1275.31% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4775.129% |
| Quantum-Si incorporated | -118.55 Million USD | -71.285% |
| GlycoMimetics, Inc. | -40.98 Million USD | -395.481% |
| PolyPid Ltd. | 6.17 Million USD | 3391.248% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 373.975% |
| Invivyd, Inc. | -198.47 Million USD | -2.315% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -8369.408% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 830.652% |
| CorMedix Inc. | -43.05 Million USD | -371.68% |
| Instil Bio, Inc. | 75.35 Million USD | 369.474% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 40.989% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 214.299% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4159.776% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -186.863% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7916.976% |
| AbCellera Biologics Inc. | -55.94 Million USD | -263.014% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -80.398% |
| Surrozen, Inc. | -32.66 Million USD | -521.694% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3904.947% |
| Verona Pharma plc | -220.44 Million USD | 7.881% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -156.004% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -55.843% |
| Evaxion Biotech A/S | 5.28 Million USD | 3941.044% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -54.693% |
| Shattuck Labs, Inc. | -121.42 Million USD | -67.24% |
| AlloVir, Inc. | -62.69 Million USD | -223.917% |
| BioVie Inc. | -17.73 Million USD | -1045.195% |
| Codexis, Inc. | -43.27 Million USD | -369.298% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -11679.002% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16991.492% |
| Agenus Inc. | 274.13 Million USD | 174.076% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5934.87% |
| Lantern Pharma Inc. | -21.7 Million USD | -835.665% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -148.316% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4543.545% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1059.751% |
| Celcuity Inc. | 6.78 Million USD | 3093.583% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -941.064% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -428.842% |
| IN8bio, Inc. | -16.38 Million USD | -1139.063% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -11289.232% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -553.82% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 342.91% |
| Liquidia Corporation | -80.17 Million USD | -153.28% |
| Quantum-Si incorporated | -118.55 Million USD | -71.285% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1149.71% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -47.43% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3365.358% |
| United Therapeutics Corporation | -507.7 Million USD | 60.002% |
| Solid Biosciences Inc. | -47.75 Million USD | -325.277% |
| Immuneering Corporation | -54.94 Million USD | -269.602% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7916.976% |
| uniQure N.V. | -102.95 Million USD | -97.249% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -510.792% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8775.526% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 595.885% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1365.574% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -704.493% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6416.252% |
| Cue Biopharma, Inc. | -33.81 Million USD | -500.461% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -961.748% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -187.24% |
| Zura Bio Limited | -99.8 Million USD | -103.465% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1597.768% |
| Elevation Oncology, Inc. | -19.11 Million USD | -962.193% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6161.795% |
| Immunome, Inc. | -97.02 Million USD | -109.288% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -802.734% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -183.052% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1377.3% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -9.472% |
| Altimmune, Inc. | -134.48 Million USD | -50.996% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 634.184% |
| Rallybio Corporation | -24.1 Million USD | -742.544% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4543.723% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -54.145% |
| Moolec Science SA | 117.61 Thousand USD | 172755.081% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -6462.924% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -14394.647% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -44.728% |
| NeurAxis, Inc. | 145.7 Thousand USD | 139475.429% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 664.005% |
| Lumos Pharma, Inc. | -28.49 Million USD | -612.701% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -183.052% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -30868.539% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1133.698% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -877.528% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 14026.77% |
| Nutriband Inc. | -251.65 Thousand USD | -80593.166% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2629.435% |
| argenx SE | -2.02 Billion USD | 89.991% |
| Neurogene Inc. | -131.95 Million USD | -53.893% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1030.831% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4036.688% |
| CervoMed Inc. | -7.79 Million USD | -2505.852% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 46.163% |
| Sesen Bio, Inc. | -112.55 Million USD | -80.422% |
| AnaptysBio, Inc. | -18.15 Million USD | -1018.781% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1018.843% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -188.53% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1907.959% |
| Achilles Therapeutics plc | -126.92 Million USD | -59.993% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -7901.182% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1441.796% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 159.692% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 955.572% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 54.618% |
| Palisade Bio, Inc. | -12.06 Million USD | -1583.412% |
| Beam Therapeutics Inc. | -262.72 Million USD | 22.705% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4061.27% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -103.355% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -8549.4% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -420.345% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -143.834% |
| Athira Pharma, Inc. | -88.99 Million USD | -128.171% |
| Vaccinex, Inc. | -1.28 Million USD | -15666.304% |
| HCW Biologics Inc. | 2.85 Million USD | 7208.612% |
| XOMA Corporation | -29 Million USD | -600.241% |
| Nektar Therapeutics | 210.24 Million USD | 196.59% |
| Arvinas, Inc. | -313.8 Million USD | 35.287% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12612.863% |
| Merus N.V. | -192.88 Million USD | -5.281% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 438.535% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2826.924% |
| Rezolute, Inc. | -68.16 Million USD | -197.896% |
| Clene Inc. | 3.34 Million USD | 6179.94% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1439.926% |
| BeyondSpring Inc. | -13.75 Million USD | -1376.336% |
| Synlogic, Inc. | -6.68 Million USD | -2937.696% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 18007.407% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2301.774% |
| Peak Bio, Inc. | 10.34 Million USD | 2063.896% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -146.384% |
| Krystal Biotech, Inc. | -350.23 Million USD | 42.019% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 263.601% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -20.163% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -6332.079% |
| MannKind Corporation | 143.89 Million USD | 241.12% |
| Ikena Oncology, Inc. | -109.15 Million USD | -86.036% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2582.208% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -513.505% |
| Gossamer Bio, Inc. | 180.35 Million USD | 212.595% |
| CohBar, Inc. | -5.93 Million USD | -3324.03% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -582.634% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4547.438% |
| Legend Biotech Corporation | -949.39 Million USD | 78.611% |
| Mural Oncology plc | -255.84 Million USD | 20.627% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 730.359% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4210.877% |
| Disc Medicine, Inc. | -358.28 Million USD | 43.321% |
| Champions Oncology, Inc. | 4.81 Million USD | 4320.075% |
| REGENXBIO Inc. | 54.76 Million USD | 470.782% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -75416.814% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -34.462% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2153.327% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -151.689% |
| Vaxart, Inc. | -8.24 Million USD | -2364.143% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -304.683% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -59.689% |
| Cellectis S.A. | -43.85 Million USD | -363.049% |
| Longeveron Inc. | -2.9 Million USD | -6883.15% |
| Repare Therapeutics Inc. | -107.85 Million USD | -88.275% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 120.97% |
| Inozyme Pharma, Inc. | 12 Million USD | 1791.686% |
| Revolution Medicines, Inc. | -608.2 Million USD | 66.612% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -16409.756% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 23.404% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -35.315% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1197.821% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -27341.892% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.877% |
| Denali Therapeutics Inc. | -74.86 Million USD | -171.248% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1593.421% |
| Veru Inc. | 4.77 Million USD | 4348.354% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1705.709% |
| Cingulate Inc. | 3.08 Million USD | 6687.443% |
| Passage Bio, Inc. | 4.58 Million USD | 4529.008% |
| Context Therapeutics Inc. | -14.44 Million USD | -1305.346% |
| Exicure, Inc. | 5.84 Million USD | 3571.876% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 11.853% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -413.192% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 66.612% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1394.181% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -245.234% |
| Nuvalent, Inc. | -335.38 Million USD | 39.452% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 11808.77% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -172.643% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2184.252% |
| OmniAb, Inc. | 9.2 Million USD | 2306.563% |
| Anew Medical, Inc. | 1.43 Million USD | 14276.263% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1339.611% |
| Lipocine Inc. | -4.75 Million USD | -4171.029% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -84.898% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1433.268% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -300.857% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 915.804% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2921.425% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -208.49% |
| Ocugen, Inc. | -32.52 Million USD | -524.427% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -137.301% |
| Q32 Bio Inc. | -37.94 Million USD | -435.127% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -32235.987% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1400.998% |
| Equillium, Inc. | -22.39 Million USD | -806.886% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -694.235% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -522.403% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -81811.139% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 251.497% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 6449.906% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 61928.456% |
| Dominari Holdings Inc. | 195 Thousand USD | 104238.462% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3755.581% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2177.335% |
| Bio-Techne Corporation | 267.74 Million USD | 175.844% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1152.823% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -71.956% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2316.637% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1505.17% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 17.155% |
| Nkarta, Inc. | 57.29 Million USD | 454.404% |
| BioCardia, Inc. | 212 Thousand USD | 95887.736% |
| Iterum Therapeutics plc | 13.43 Million USD | 1611.162% |